IgA nephropathy Archives - Medical Conferences

Atrasentan shows positive interim results in IgA nephropathy: ALIGN phase 3 trial

Presented By

Prof. Hiddo J.L. Heerspink, University Medical Center Groningen, The Netherlands

Trial

Phase 3, ALIGN

Conference

ERA 2024

Type

News article

20 June 2024 19:05

Zigakibart slows down eGFR decline in IgA nephropathy

Presented By

Prof. Jonathan Barrat, University of Leicester, United Kingdom

Trial

Phase 1/2, ADU-CL-19

Conference

ERA 2024

Type

News article

20 June 2024 19:01

Long-term atacicept shows continued benefit in IgA nephropathy

Presented By

Prof. Richard Lafayette, Stanford University, CA, USA

Trial

Phase 2, ORIGIN

Conference

ERA 2024

Type

News article

20 June 2024 18:58

APPLAUSE-IgAN: Iptacopan improves proteinuria in IgA nephropathy

Presented By

Prof. Vlado Perkovic, University of New South Wales, Sydney, Australia

Trial

Phase 3, APPLAUSE-IgAN

Conference

ERA 2024

Type

News article

20 June 2024 18:53

Sparsentan outperforms irbesartan for treatment of IgAN

Presented By

Prof. Brad Rovin, Ohio State University, OH, USA

Trial

Phase 3, PROTECT

Conference

ASN 2023

Type

News article

28 November 2023 14:33

Cemdisiran shows promise in IgA nephropathy

Presented By

Prof. Jonathan Barratt, University of Leicester, UK

Trial

Phase 2

Conference

ASN 2022

Type

Peer-reviewed article

8 December 2022 14:58